bpc-157 fda status approval advisory committee votes to add popular peptide to drug compounding list 2026 FDA Peptide Reclassification |

Animal studies have suggested a potential link to thyroid tumors, though this has not been proven in humans (FDA prescribing information for Wegovy)

doi:10.1016/j.urology.2021.04.019

It stimulates metalloproteinase activity, the enzymes responsible for breaking down and remodeling damaged tissue, while simultaneously increasing anti-protease expression to prevent excessive tissue degradation

The information above is provided for reference

Unlike pills, injections deliver nutrients directly into your bloodstream for better absorption

One compound that has generated a significant amount of buzz, and an equal amount of controversy, is BPC-157